These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27223479)

  • 21. Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database.
    Rehman H; Akeroyd JM; Ramsey D; Ahmed ST; Merchant AT; Navaneethan SD; Petersen LA; Virani SS
    Clin Cardiol; 2017 Nov; 40(11):1055-1060. PubMed ID: 28841246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Access to Specialty Services: Opportunities for Expansion of Telemedicine to Support Correctional Health Care in Colorado.
    Krsak M; Jeffers A; Shah J; Johnson SC; Montague BT
    Telemed J E Health; 2020 Jun; 26(6):776-783. PubMed ID: 31486710
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of the Impact of a Pharmacist-Led Telehealth Clinic on Diabetes-Related Goals of Therapy in a Veteran Population.
    Maxwell LG; McFarland MS; Baker JW; Cassidy RF
    Pharmacotherapy; 2016 Mar; 36(3):348-56. PubMed ID: 26877253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV Subspecialty Care in Correctional Facilities Using Telemedicine.
    Young JD; Patel M
    J Correct Health Care; 2015 Apr; 21(2):177-85. PubMed ID: 25788612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus: 5 year results of the IDEATel study.
    Shea S; Weinstock RS; Teresi JA; Palmas W; Starren J; Cimino JJ; Lai AM; Field L; Morin PC; Goland R; Izquierdo RE; Ebner S; Silver S; Petkova E; Kong J; Eimicke JP;
    J Am Med Inform Assoc; 2009; 16(4):446-56. PubMed ID: 19390093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes management in correctional institutions.
    American Diabetes Association
    Diabetes Care; 2007 Jan; 30 Suppl 1():S77-84. PubMed ID: 17192382
    [No Abstract]   [Full Text] [Related]  

  • 27. Type 2 diabetes mellitus management in Canada: is it improving?
    Leiter LA; Berard L; Bowering CK; Cheng AY; Dawson KG; Ekoé JM; Fournier C; Goldin L; Harris SB; Lin P; Ransom T; Tan M; Teoh H; Tsuyuki RT; Whitham D; Woo V; Yale JF; Langer A
    Can J Diabetes; 2013 Apr; 37(2):82-9. PubMed ID: 24070797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effectiveness and safety of liraglutide in clinical practice.
    Ponzani P
    Minerva Endocrinol; 2013 Mar; 38(1):103-12. PubMed ID: 23435446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of telemedicine intervention on hypoglycaemia in diabetes patients: A systematic review and meta-analysis of randomised controlled trials.
    Hu Y; Wen X; Wang F; Yang D; Liu S; Li P; Xu J
    J Telemed Telecare; 2019 Aug; 25(7):402-413. PubMed ID: 29909748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telemedicine for Diabetes Mellitus Management in Older Adults: A Systematic Review.
    Tristão LS; Tavares G; Tustumi F; Bernardo WM; Duarte ML; Peccin MS; Dos Santos LR
    Curr Diabetes Rev; 2023; 19(4):e190522205042. PubMed ID: 35619303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inadequate control of blood pressure in Nigerians with diabetes.
    Okoro EO; Oyejola BA
    Ethn Dis; 2004; 14(1):82-6. PubMed ID: 15002927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hba1c, Blood Pressure, and Lipid Control in People with Diabetes: Japan Epidemiology Collaboration on Occupational Health Study.
    Hu H; Hori A; Nishiura C; Sasaki N; Okazaki H; Nakagawa T; Honda T; Yamamoto S; Tomita K; Miyamoto T; Nagahama S; Uehara A; Yamamoto M; Murakami T; Shimizu C; Shimizu M; Eguchi M; Kochi T; Imai T; Okino A; Kuwahara K; Kashino I; Akter S; Kurotani K; Nanri A; Kabe I; Mizoue T; Kunugita N; Dohi S;
    PLoS One; 2016; 11(7):e0159071. PubMed ID: 27437997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
    Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
    Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
    Bakris GL; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Wright JT; Oakes R; Lukas MA; Anderson KM; Bell DS;
    JAMA; 2004 Nov; 292(18):2227-36. PubMed ID: 15536109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation.
    Zibadi S; Rohdewald PJ; Park D; Watson RR
    Nutr Res; 2008 May; 28(5):315-20. PubMed ID: 19083426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factor Control in Stroke Survivors with Diagnosed and Undiagnosed Diabetes: A Ghanaian Registry Analysis.
    Sarfo FS; Akassi J; Agyei M; Kontoh S; Ovbiagele B
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105304. PubMed ID: 32992189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of patients prescribed angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or the combination at an urban medical center.
    Masri G; Bledsoe K; Palacio C
    MedGenMed; 2007 Nov; 9(4):40. PubMed ID: 18311390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease.
    Changsirikulchai S; Sangthawan P; Janma J; Sripaiboonkij N; Rattanamongkolgul S; Thinkhamrop B
    Nephrology (Carlton); 2018 Jan; 23(1):53-59. PubMed ID: 27608176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treat-to-target HbA
    Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
    Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.